HIVClinicalForum
Meeting category
Date(s)
15 Sep 2022
Program Language
Portuguese, English
Location
Salvador, BA, Brazil
Meeting type
Hybrid Meeting
Organizer

Salvador HIV Clinical Forum 2022

Related Enduring Materials

Enduring Materials
Final Program
Session 1 | Antiretroviral Therapy 2022 - State of ART Plenary Lectures - 8:35
8:35 BRT
International and Local Guidelines - Focus on Patients' Needs?
Eduardo Sprinz, MD
Universidade Federal do Rio Grande do Sul, Brazil
08:55 BRT
Is Resistance a Concern When Starting ART?
Monica Gandhi, MD, MPH
University of California San Francisco, United States
09:15 BRT
Polypharmacy and ART Choice
Esper Kallas, MD, PhD
University of São Paulo, Brazil
09:35 BRT
Choosing the Best Regimen For Older Patients With Comorbidities
Tânia Vergara, MD, PhD
Sociedade de Infectologia do Rio de Janeiro, Brazil
Session 2 | HIV Prevention in 2022 - 10:45
10:45 BRT
Update on Therapeutic Options for HIV Prevention
Beatriz Grinsztejn, MD, PhD
Instituto de Pesquisa Clinica Evandro Chagas-Fiocruz, Brazil
11:05 BRT
PrEP On-Demand vs Conventional
Esper Kallas, MD, PhD
University of São Paulo, Brazil
11:25 BRT
Community Perspective on Therapeutic PrEP Options
Alícia Krüger, PharmD, MPH
Paraná State Health Department, Brazil
11:45 BRT
Clinical Case (focused on prevention)
Gustavo Magalhães, MD, PhD
Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil
Session 3 | Starting and Switching Antiretroviral Therapy in 2022 - 13:20
13:20 BRT
Role of Nukes and Non-nukes in Current ART
Luis E. Soto-Ramírez, MD
Instituto Nacional de Ciencias Médicas y Nutrición, Mexico
13:40 BRT
Role of PIs on Current ART
Estevão Portela Nunes, MD, PhD
Fundação Oswaldo Cruz (Fiocruz), Brazil
14:00 BRT
Clinical Case (focused on starting and switching therapy)
Monica Gomes, MD, PhD
Universidade Federal do Parana, Hospital de Clínicas, Brazil
Session 4 | Optimal Care of Highly Treatment Experienced Patients - Now and in the Future - 15:05
15:05 BRT
Current and Evolving Therapeutic Options for Highly Treatment Experienced Patients
Monica Gandhi, MD, MPH
University of California San Francisco, United States
15:25 BRT
Resistance to INSTI: what can we expect?
Ricardo Diaz, MD
Federal University of Sao Paulo - UNIFESP, Brazil
15:45 BRT
Clinical Case (focused on highly treatment experienced patients)
Fabianna Bahia, MD, PhD
Universitary Hospital Professor Edgard Santos, Brazil
Overview
Image
HCF_Salvador
Overview

The Salvador HIV Clinical Forum 2022 provided an independent scientific program involving the world’s leading experts. It was specifically designed for Brazilian HIV healthcare professionals, focused on optimizing treatment for their patients. The meeting aimd to increase the knowledge and skills through lectures on novel treatment strategies, long-acting preparations, and the care of complex patients.

This program featured challenging plenary lectures followed by Q&A and debates, stimulating interactions, and the sharing of knowledge within the HIV-treating community. The program included networking opportunities for community building providing delegates with the unique opportunity to meet their colleagues in a focused and scientific setting.

The HIV Clinical Forum is a series of interactive programs that provide an independent scientific program on emerging topics in HIV involving experts where HIV clinicians and allied healthcare professionals receive updates on the latest developments related to comprehensive HIV management, where they can share their clinical experience and present the results from their ongoing and completed cohorts/ research programs.

Furthermore, the HIV Clinical Forum provides an educational setting where healthcare professionals can acquire specific skills that will enhance their capabilities to interpret research results and even develop new research projects. Maintaining these programs in a flexible format through the COVID-19 crisis is crucial for HIV infected patients.

Program Directors
General Information 
COVID-19 Update
The Salvador HIV Clinical Forum 2022 will be held as a live meeting.

We are available to answer any questions or concerns that you may have about your participation at the Salvador HIV Clinical Forum 2022. For more information, please contact Ms. Dagmar Jónasdóttir at dagmar@amededu.com.

To stay updated on developments about this meeting, make sure that you are signed up for our newsletter.
Who Should Attend?
- Primary: medical doctors involved in the management and treatment of people living with HIV in the region
- Secondary: researchers
- Tertiary: healthcare workers, clinical virologists, microbiologists, scientists, pharmacologists, nurses, post-doctoral researchers, students, and other healthcare professionals involved in treating people living with HIV
Meeting Objectives
With the HIV Clinical Forum program we aim to:

- Build a community of healthcare professionals devoted to providing optimal clinical care
for their patients
- Create a platform for interactive information exchange on novel treatment strategies and options
- Translate the latest studies and research achievements into clinical guidance for the optimal management of people living with HIV
Learning Objectives
After participating in the HIV Clinical Forum, participants will be able to:

- Understand the scientific rationale and clinical data supporting novel treatment strategies
- Describe the pros and cons of novel treatment strategies and drugs
- Understand how to integrate novel treatment strategies into routine patient care
- Be knowledgeable of the clinical data supporting long-acting injectable regimens
- Identify patients who might most benefit from long-acting injectable regimens
- Gain knowledge on how to optimally integrate injectable drugs into routine clinical care
- Improve their skills in defining and identifying treatment experienced people living with HIV
- Stay informed on new drug options for treatment experienced people living with HIV
- Understand how best to use new treatment options for highly treatment experienced people living with HIV
Practical Information 
Certificate of Attendance
A certificate of attendance will be sent by e-mail shortly after the forum meeting.
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Language
The official language of this meeting is Portuguese. English translation will be available.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Meeting Materials
An official program and speakers' bios will be sent by e-mail prior to the meeting.
Payment and Procedure of Online Registration
The registration fee is waived for all healthcare professionals. Should you need any assistance with registering, please contact Ms. Dagmar Jónasdóttir at dagmar@amededu.com.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.

Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.

Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Committees

More information will be available soon.

Support

The Salvador HIV Clinical Forum 2022 is supported by an independent educational grant from ViiV Healthcare.

ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.

Endorsers
Previous Editions
Top-Rated Materials from Previous Editions

Use of INSTI in Patients With Comorbidities and Polypharmacy - Marta Boffito, MD, PhD, FRCP

Salvador HIV Clinical Forum 2021

Language
Ratings previous edition
Content is relevant to my practice​
4.2
(53)
Content was free from commercial bias​
4.3
(53)
Overall event experience​
4.8
(53)